Innovative Prostate Cancer Treatment Known as Sonablate(R) HIFU Now Available at Third Sit...( CHARLOTTE N.C. July 17 /-...),Health

CHARLOTTE, N.C., July 17 /PRNewswire/ -- India High Intensity Focused Ultrasound Devices Private Limited (India HIFU), an affiliate of US HIFU -- a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies -- officially launches Sonablate((R)) HIFU services for the treatment of prostate cancer in New Delhi's Rajiv Gandhi Cancer Institute & Research Centre (RGCI & RC) on July 17 at 7:00 p.m. at Hotel Le Meridian, Janpath, New Delhi. Local dignitaries, hospital executives and India HIFU personnel are on the evening's agenda, including:

       Dr. Kiran Walia, Honorable Health Minister, Government of NCT of Delhi
       Mr. D. S. Negi, CEO, RGCI & RC
       Dr. A. K. Chaturvedi, Medical Director, RGCI & RC
       Dr. Sudhir Rawal, Senior Consultant, Uro-Genito Surgical Oncology,
        RGCI & RC
       Mr. Mukesh Rana, Country Manager, India HIFU

"Sonablate HIFU on initial use is very patient friendly for those who are suffering from carcinoma prostate as there is no immediate morbidity which is expected if the patient chooses radical surgery. The long term side effects are also reduced since the treatment is done by sound waves rather than radiation," said Dr. Sudhir Rawal, who has performed Sonablate HIFU in India already and will continue at RGCI & RC. "The treatment is most convenient as the patient is admitted only for one day and, since there is no blood loss during procedure, can return to work very quickly."

With the addition of Rajiv Gandhi hospital, there are now three centers in India that offer Sonablate HIFU to men with localized prostate cancer. The first Sonablate HIFU services in India were performed by Dr. Ramesh Ramayya at Dr. Ramayya's Pramila Urology Hospital in Hyderabad in December 2008. The second location in India to offer HIFU as a minimally i
'/>"/>